Shares of Sorrento Therapeutics slid by a staggering 10.84% to $11.43 at 11:26 EST on Tuesday, after two sequential sessions in a row of gains. NASDAQ Composite is falling 1.72% to $13,300.74, following last session’s downward trend, This seems, as yet, an all-around negative trend trading session today.

Sorrento Therapeutics’s last close was $14.63, 69.64% under its 52-week high of $19.39.

Sorrento Therapeutics’s Sales

Sorrento Therapeutics’s sales growth is 7663.5% for the current quarter and 166.3% for the next. The company’s growth estimates for the present quarter and the next is 761% and 200%, respectively.

Sorrento Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 103.4%, now sitting on 41.52M for the twelve trailing months.

Volatility

Sorrento Therapeutics’s last day, last week, and last month’s average volatility was 15.56%, 20.41%, and 8.14%, respectively.

Sorrento Therapeutics’s last day, last week, and last month’s high and low average amplitude percentage was 10.79%, 24.77%, and 12.21%, respectively.

Sorrento Therapeutics’s Stock Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $11.43 at 11:26 EST, way below its 52-week high of $19.39 and way higher than its 52-week low of $1.55.

Sorrento Therapeutics’s Moving Average

Sorrento Therapeutics’s worth is above its 50-day moving average of $11.04 and way above its 200-day moving average of $9.36.

LEAVE A REPLY

Please enter your comment!
Please enter your name here